$1.11
0.065.71%
Last update: Oct 9, 4:00 PM
TELA Bio Inc
TELANASDAQ
TELA Bio (TELA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TELA Bio (TELA) last issued guidance on May 12, 2026 for fiscal year 2026. The company guided revenue in the range of for the period.
Compared to prior guidance, TELA Bio raised its revenue forecast from a prior range of $19M - $19M.
TELA Bio has issued 16 guidance updates between November 9, 2022 and May 12, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.18 | $-0.18 | $-0.18 | $-0.19 |
| Actual | $-0.20 | $-0.21 | $-0.17 | $-0.19 |
| Surprise | -11.1% | -16.7% | +5.56% | 0.00% |
| Revenue | ||||
| Estimate | $20.0M | $18.9M | $21.0M | $21.8M |
| Actual | $19.3M | $19.1M | $20.9M | $20.7M |
| Surprise | -3.58% | +0.84% | -0.74% | -5.17% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.16 | $-0.13 | $-0.10 | $-0.11 |
| Revenue | ||||
| Consensus | $19.8M | $21.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.20 | $-0.18 | -11.1 % |
| Q1 | May 12, 2026 | $-0.21 | $-0.18 | -16.7 % |
| Q4 | Mar 24, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q3 | Nov 13, 2025 | $-0.19 | $-0.19 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $19.29M | $20.01M | -3.58 % |
| Q1 | May 12, 2026 | $19.06M | $18.90M | 0.84 % |
| Q4 | Mar 24, 2026 | $20.87M | $21.02M | -0.74 % |
| Q3 | Nov 13, 2025 | $20.70M | $21.83M | -5.17 % |
